NCT05693948已完成不适用
The Efficacy of Topical Serum X Containing Arbutin and Glutathione for Skin Brightening
Ungku Shahrin Medical Aesthetic Research & Innovation (USMARI) Centre1 个研究点 分布在 1 个国家目标入组 34 人开始时间: 2022年9月1日最近更新:
适应症
干预措施
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 34
- 试验地点
- 1
- 主要终点
- Changes in skin tone from baseline and at week 4, week 8, and week 12 after usage of serum X.
研究概览
简要总结
This study is conducted to evaluate the effectiveness of topical serum X containing arbutin and glutathione for skin brightening. The study duration is 12 weeks and the skin assessment will be carried out at baseline, week 4, 8 and week 12.The main questions this study aims to answer are:
- The skin brightening effect of the product on facial skin.
- To observe any adverse effect occurrence with the usage of the product.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Other
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 30 Years（Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •Malaysia citizen
- •Male and female (age 18-30 years old)
排除标准
- •Participant with severe acne skin condition
- •Participant who is taking isotretinoin, immunocompromised patients and received laser and light treatment within the last three months
- •Participant who undergo whitening or cosmetic treatments such as botox and dermal fillers within the previous six month
- •Participant with a history of facial surgery such as facelift or nose reshaping
- •Participant with history of allergies to any ingredient in the study product
- •Participant who is pregnant or plan to get pregnant
研究组 & 干预措施
Serum X
Experimental
Participants will used serum X twice daily for 12 weeks
干预措施: Other: Serum X (Other)
结局指标
主要结局
Changes in skin tone from baseline and at week 4, week 8, and week 12 after usage of serum X.
时间窗: Baseline and at week 4, week 8, and week 12
Skin tone will be assessed using JANUS III skin analyzer
Adverse effect after using serum X
时间窗: Week 12
Based on adverse effect occurrence on participants that occur during study period (12 weeks
次要结局
未报告次要终点
研究者
研究点 (1)
Loading locations...
相似试验
暂停
2 期
Efficiency And Safety Of Association Arbutin, Triamcinolone And Tretinoin In Treatment Of MelasmaMelasmaNCT00717652Azidus Brasil110
已完成
2 期
Ruxolitinib Cream in the Treatment of Cutaneous Necrobiosis LipoidicaNecrobiosis LipoidicaNCT04492618Aaron R. Mangold12
已完成
2 期
Study of Ruxolitinib Cream for the Treatment of Discoid Lupus ErythematosusDiscoid Lupus ErythematosusNCT04908280University of Rochester10
已完成
3 期
TRuE AD2 - An Efficacy and Safety Study of Ruxolitinib Cream in Adolescents and Adults With Atopic DermatitisAtopic DermatitisNCT03745651Incyte Corporation618
已完成
1 期
Effectiveness and Safety of Topical Ranibizumab for Treatment of Corneal Neovascularization (NV)Corneal NeovascularizationNCT00681889Reza Dana, MD9